Preparation and biological evaluation of 64Cu-CB-TE2A-sst 2-ANT, a somatostatin antagonist for PET imaging of somatostatin receptor-positive tumors

Journal of Nuclear Medicine

Volumn 49, Issue 11, 2008, Pages 1819-1827

  Wadas, Thaddeus J ^a   Eiblmaier, Martin ^a   Zheleznyak, Alexander ^a   Sherman, Christopher D ^a   Ferdani, Riccardo ^a   Liang, Kexian ^a   Achilefu, Samuel ^a   Anderson, Carolyn J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

64Cu; Antagonist; Somatostatin

Indexed keywords

4,11 BIS(CARBOXYMETHYL) 1,4,8,11 TETRAAZABICYCLO[6.6.2]HEXADECANE 3 TYROSINE OCTREOTATE CU 64; 4,11 BIS(CARBOXYMETHYL) 1,4,8,11 TETRAAZABICYCLO[6.6.2]HEXADECANE SOMATOSTATIN RECEPTOR 2 ANT CU 64; CHELATING AGENT; RADIOPHARMACEUTICAL AGENT; SOMATOSTATIN RECEPTOR 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING SITE; CELL MEMBRANE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DISSOCIATION CONSTANT; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG SYNTHESIS; INTERNALIZATION; KIDNEY CLEARANCE; LIVER CLEARANCE; MALE; MOLECULAR IMAGING; NONHUMAN; PANCREAS TUMOR; PLASMA CLEARANCE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; TUMOR CELL;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE, TUMOR; MALE; NEOPLASMS; ORGANOMETALLIC COMPOUNDS; PEPTIDES; POSITRON-EMISSION TOMOGRAPHY; RADIOCHEMISTRY; RADIOPHARMACEUTICALS; RATS; RECEPTORS, SOMATOSTATIN; TISSUE DISTRIBUTION;

EID: 57349185212     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.108.054502     Document Type: Article

References (28)

1. 111In]-DTPA-D-Phe1-octreotide to human ovarian tumor xenografts induced to express the somatostatin receptor subtype 2 using an adenoviral vector. Clin Cancer Res. 1999;5:383-393.
2. 64Cu-TETA- octreotide as a PET imaging agent for patients with neuroendocrine tumors. J Nucl Med. 2001;42:213-221.
3. Li WP, Meyer LA, Anderson CJ. Radiopharmaceuticals for positron emission tomography imaging of somatostatin receptor positive tumors. Top Curr Chem. 2005;252:179-192.
4. Edwards WB, Xu B, Akers W, et al. Agonist-antagonist dilemma in molecular imaging: evaluation of a monomolecular multimodal imaging agent for the somatostatin receptor. Bioconjug Chem. 2008;19:192-200.
5. Ginj M, Zhang H, Waser B, et al. Radiolabeled somatostatin receptor antagonists are preferable to agonists for in vivo peptide receptor targeting of tumors. Proc Natl Acad Sci USA. 2006;103:16436-16441.
6. Wadas TJ, Wong EH, Weisman GR, Anderson CJ. Copper chelation chemistry and its role in copper radiopharmaceuticals. Curr Pharm Des. 2007;13:3-16.
7. Hubin TJ, McCormick JM, Collinson SR, Alcock NW, Busch DH. Ultra rigid cross-bridged tetraazamacrocycles as ligands: the challenge and the solution. J Chem Soc Chem Commun. 1998;16:1675-1676.
8. Weisman GR, Rogers ME, Wong EH, Jasinski JP, Paight ES. Cross-bridged cyclam: protonation and Li+ complexation in a diamond-lattice cleft. J Am Chem Soc. 1990;112:8604-8605.
9. Boswell CA, Sun X, Niu W, et al. Comparative in vivo stability of copper-64-labeled cross-bridged and conventional tetraazamacrocyclic complexes. J Med Chem. 2004;47:1465-1474.
10. Sprague JE, Peng Y, Sun X, et al. Preparation and biological evaluation of copper-64-labeled Tyr3-octreotate using a cross-bridged macrocyclic chelator. Clin Cancer Res. 2004;10:8674-8682.
11. 124I. Radiochim Acta. 2007;95:67-73.
12. McCarthy DW, Shefer RE, Klinkowstein RE, et al. The efficient production of high specific activity Cu-64 using a biomedical cyclotron. Nucl Med Biol. 1997;24:35-43.
13. Achilefu S, Wilhelm RR, Jimenez HN, Schmidt MA, Srinivasan A. A new method for the synthesis of tri-tert-butyl diethylenetriaminepentaacetic acid and its derivatives. J Org Chem. 2000;65:1562-1565.
14. Achilefu S, Jimenez HN, Dorshow RB, et al. Synthesis, in vitro receptor binding and in vivo evaluation of fluorescein and carbocyanine peptide-based optical contrast agents. J Med Chem. 2002;45:2003-2015.
15. Wadas TJ, Anderson CJ. Radiolabeling of TETA- and CB-TE2A-conjugated peptides with copper-64. Nat Protoc. 2006;1:3062-3068.
16. Anderson CJ, Jones LA, Bass LA, et al. Radiotherapy, toxicity and dosimetry of copper-64-TETA-octreotide in tumor-bearing rats. J Nucl Med. 1998;39:1944-1951.
17. Wang M, Caruano AL, Lewis MR, Meyer LM, VanderWaal RP, Anderson CJ. Subcellular localization of radiolabeled somatostatin analogues: implications for targeted radiotherapy of cancer. Cancer Res. 2003;63:6864-6869.
18. 3-octreotate: a new somatostatin analog with improved target tissue uptake. Nucl Med Biol. 1999;26:267-273.
19. 111In- octreotide. J Nucl Med. 2000;41:1114-1119.
20. Hofsli E, Thommesen L, Norsett K, et al. Expression of chromogranin A and somatostatin receptors in pancreatic AR42J Cells. Mol Cell Endocrinol. 2002;194:165-173.
21. Reubi JC, Schar J-C, Waser B, et al. Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use. Eur J Nucl Med. 2000;27:273-282.
22. Liu Q, Cescato R, Dewi DA, Rivier J, Reubi JC, Schonbrunn A. Receptor signaling and endocytosis are differentially regulated by somatostatin analogs. Mol Pharmacol. 2005;68:90-101.
23. Cohn J. Vasoactive intestinal peptide stimulates protein phosphorylation in a colonic epithelial cell line. Am J Physiol. 1987;16:G420-G424.
24. Breeman WAP, de Jong M, Bernard B, et al. Tissue distribution and metabolism of radioiodinated DTPA(0), D-Tyr(1) and Tyr(3) derivatives of octreotide in rats. Anticancer Res. 1998;18:83-89.
25. 111In-DTPA-conjugated peptides. Nucl Med Biol. 2001;28:761-768.
26. Jones-Wilson TM, Deal KA, Anderson CJ, et al. The in vivo behavior of copper-64-labeled azamacrocyclic compounds. Nucl Med Biol. 1998;25:523-530.
27. Ginj M, Zhang H, Eisenwiener K, et al. New pansomatostatin ligands and their chelated versions: affinity, profile, agonist activity, internalization, and tumor targeting. Clin Cancer Res. 2008;14:2019-2027.
28. Ludvigsen E, Olsson R, Stridsberg M, Janson ET, Sandler S. Expression and distribution of somatostatin receptor subtypes in the pancreatic islets of mice and rats. J Histochem Cytochem. 2004;52:391-400.